Genocea Biosciences

BiotechnologySeries CCambridge, USgenocea.com

See the investors Find investors for my raise

Latest round: Series C
Last raised: Oct 2012
Total raised: $73M
Investors: 13

About Genocea Biosciences

Genocea Biosciences, Inc. is a biotechnology company focused on developing vaccines and immunotherapies for cancer and infectious diseases.Genocea Biosciences, Inc. was founded in 2006 and is headquartered in Cambridge, US. The company specializes in immunotherapy, focusing on harnessing the immune system for therapeutic purposes.25 each.Genocea Biosciences delivers innovative products primarily in the fields of cancer and infectious disease immunotherapy. The company plans to introduce new products targeting various infectious diseases and cancer treatments within the next few years.

Who invested in Genocea Biosciences

13 investors across 4 rounds

See all investors in Genocea Biosciences

Funding rounds

Series C
Oct 10, 2012
Amount
$15M
Investors
Locked
Series B
Jan 3, 2011
Amount
$35M
Investors
Locked
Series A
Feb 19, 2009
Amount
$23M
Investors
Locked
Seed
Jun 1, 2006
Amount
Undisclosed
Investors
Locked

Questions about Genocea Biosciences

Who invested in Genocea Biosciences?

Genocea Biosciences has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Genocea Biosciences raised?

Genocea Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Genocea Biosciences last raise money?

Genocea Biosciences's most recent round on record is a Series C, in Oct 2012.

What does Genocea Biosciences do?

Genocea Biosciences is a biotechnology company.

Where is Genocea Biosciences headquartered?

Genocea Biosciences is headquartered in Cambridge, US.

Which VCs invest in companies like Genocea Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Genocea Biosciences's stage. Their profiles are linked below.

VCs backing biotechnology startups at Series C

Andreessen HorowitzUS · Cheque $3.8M–$81.3M$21.5B dry powder Founders FundUS · Cheque $696K–$57.5M$10.8B dry powder AccelUS · Cheque $1.1M–$31.9M$9.4B dry powder Thrive CapitalUS · Cheque $225K–$30.6M$8.9B dry powder Kleiner PerkinsUS · Cheque $2M–$32.5M$4.5B dry powder Lightspeed Venture PartnersUS · Cheque $1.7M–$35.8M$4B dry powder

Raising like Genocea Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.